Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Army
McKesson
Johnson and Johnson
Covington
AstraZeneca
Express Scripts
Daiichi Sankyo
Deloitte

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022051

« Back to Dashboard

NDA 022051 describes FLONASE SENSIMIST ALLERGY RELIEF, which is a drug marketed by Glaxosmithkline Cons and is included in one NDA. It is available from three suppliers. There are eight patents protecting this drug. Additional details are available on the FLONASE SENSIMIST ALLERGY RELIEF profile page.

The generic ingredient in FLONASE SENSIMIST ALLERGY RELIEF is fluticasone furoate. There are twenty-six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the fluticasone furoate profile page.
Summary for 022051
Tradename:FLONASE SENSIMIST ALLERGY RELIEF
Applicant:Glaxosmithkline Cons
Ingredient:fluticasone furoate
Patents:8
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 022051
Suppliers and Packaging for NDA: 022051
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLONASE SENSIMIST ALLERGY RELIEF fluticasone furoate SPRAY, METERED;NASAL 022051 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0135-0615 N 0135-0615-01
FLONASE SENSIMIST ALLERGY RELIEF fluticasone furoate SPRAY, METERED;NASAL 022051 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0135-0615 N 0135-0615-02

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:SPRAY, METERED;NASALStrength0.0275MG/SPRAY
Approval Date:Aug 2, 2016TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Aug 3, 2021Product Flag?YSubstance Flag?Delist Request?
Patented Use:OTC USE: ALLERGY SYMPTOM RELIEVER; TEMPORARILY RELIEVES THESE SYMPTOMS DUE TO HAY FEVER OR OTHER UPPER RESPIRATORY ALLERGIES; NASAL CONGESTION, RUNNY NOSE, SNEEZING, ITCHY NOSE, AND (ITCHY WATER EYES (AGES 12 AND UP))
Patent:➤ Try a Free TrialPatent Expiration:Aug 3, 2021Product Flag?YSubstance Flag?YDelist Request?
Patented Use:OTC USE: ALLERGY SYMPTOM RELIEVER; TEMPORARILY RELIEVES THESE SYMPTOMS DUE TO HAY FEVER OR OTHER UPPER RESPIRATORY ALLERGIES; NASAL CONGESTION, RUNNY NOSE, SNEEZING, ITCHY NOSE, AND (ITCHY WATER EYES (AGES 12 AND UP))
Patent:➤ Try a Free TrialPatent Expiration:Aug 3, 2021Product Flag?YSubstance Flag?Delist Request?
Patented Use:OTC USE: ALLERGY SYMPTOM RELIEVER; TEMPORARILY RELIEVES THESE SYMPTOMS DUE TO HAY FEVER OR OTHER UPPER RESPIRATORY ALLERGIES; NASAL CONGESTION, RUNNY NOSE, SNEEZING, ITCHY NOSE, AND (ITCHY WATER EYES (AGES 12 AND UP))

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Julphar
US Department of Justice
Queensland Health
McKinsey
Chinese Patent Office
Chubb
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.